N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide

C53H69N13O13 — CID 175972918

IUPACN-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide
SMILESCCOCCOCCOCC(NC(=O)c1cc(NC(=O)c2nc(NC(=O)c3cc(NC(=O)c4ccc5nc(-c6nccn6C)[nH]c5c4)cn3C)cn2C)cn1C)OCCOCCOCCOCCOCCOc1ccc(N)cc1
InChIInChI=1S/C53H69N13O13/c1-6-71-15-16-72-23-24-77-35-46(79-28-26-76-22-20-74-18-17-73-19-21-75-25-27-78-40-10-8-37(54)9-11-40)62-52(69)44-31-39(33-65(44)4)57-53(70)49-60-45(34-66(49)5)61-51(68)43-30-38(32-64(43)3)56-50(67)36-7-12-41-42(29-36)59-47(58-41)48-55-13-14-63(48)2/h7-14,29-34,46H,6,15-28,35,54H2,1-5H3,(H,56,67)(H,57,70)(H,58,59)(H,61,68)(H,62,69)
InChIKeyAZILTHAFXOXRDB-UHFFFAOYSA-N
MW1096.21 g/mol
LogP4.00
Rot. Bonds35

About N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide

N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide (PubChem CID 175972918) has the molecular formula C53H69N13O13 and a molecular weight of 1096.21 g/mol. Its IUPAC name is N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide.

Molecular Properties

Compound NameN-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide
PubChem CID175972918
Molecular FormulaC53H69N13O13
Molecular Weight1096.21 g/mol
Exact Mass1095.51
IUPAC NameN-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide
SMILESCCOCCOCCOCC(NC(=O)c1cc(NC(=O)c2nc(NC(=O)c3cc(NC(=O)c4ccc5nc(-c6nccn6C)[nH]c5c4)cn3C)cn2C)cn1C)OCCOCCOCCOCCOCCOc1ccc(N)cc1
InChIInChI=1S/C53H69N13O13/c1-6-71-15-16-72-23-24-77-35-46(79-28-26-76-22-20-74-18-17-73-19-21-75-25-27-78-40-10-8-37(54)9-11-40)62-52(69)44-31-39(33-65(44)4)57-53(70)49-60-45(34-66(49)5)61-51(68)43-30-38(32-64(43)3)56-50(67)36-7-12-41-42(29-36)59-47(58-41)48-55-13-14-63(48)2/h7-14,29-34,46H,6,15-28,35,54H2,1-5H3,(H,56,67)(H,57,70)(H,58,59)(H,61,68)(H,62,69)
InChIKeyAZILTHAFXOXRDB-UHFFFAOYSA-N
XLogP4.00
TPSA299.67 Ų
H-Bond Donors6
H-Bond Acceptors21
Rotatable Bonds35
Heavy Atoms79
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001096.21
LogP ≤ 54.00
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_no_alk(40)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'aniline', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide?
The IUPAC name of N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide (CID 175972918) is N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide.
What is the SMILES notation for N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide?
The canonical SMILES for N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide is CCOCCOCCOCC(NC(=O)c1cc(NC(=O)c2nc(NC(=O)c3cc(NC(=O)c4ccc5nc(-c6nccn6C)[nH]c5c4)cn3C)cn2C)cn1C)OCCOCCOCCOCCOCCOc1ccc(N)cc1.
What is the InChIKey of N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide?
The InChIKey is AZILTHAFXOXRDB-UHFFFAOYSA-N. The full InChI is InChI=1S/C53H69N13O13/c1-6-71-15-16-72-23-24-77-35-46(79-28-26-76-22-20-74-18-17-73-19-21-75-25-27-78-40-10-8-37(54)9-11-40)62-52(69)44-31-39(33-65(44)4)57-53(70)49-60-45(34-66(49)5)61-51(68)43-30-38(32-64(43)3)56-50(67)36-7-12-41-42(29-36)59-47(58-41)48-55-13-14-63(48)2/h7-14,29-34,46H,6,15-28,35,54H2,1-5H3,(H,56,67)(H,57,70)(H,58,59)(H,61,68)(H,62,69).
What are the key properties of N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide?
N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide has a molecular weight of 1096.21 g/mol, XLogP of 4.00, 35 rotatable bonds, 6 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[[2-[[5-[[1-[2-[2-[2-[2-[2-(4-aminophenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-2-[2-(2-ethoxyethoxy)ethoxy]ethyl]carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylpyrrol-3-yl]-2-(1-methylimidazol-2-yl)-3H-benzimidazole-5-carboxamide is sourced from PubChem (CID 175972918), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).